Clinical Study of the Presence of Trichomonas Tenax and Entamoeba Gingivalis in Patients With Periodontitis (Paro-Proto 2)

November 13, 2017 updated by: Central Hospital, Nancy, France

Preliminary Clinical Study of the Presence of Trichomonas Tenax and Entamoeba Gingivalis in Patients With Periodontitis Consulting to CHU of Nancy, in Periodontal Department.

The buccal cavity presents microorganismes whose the number and composition vary with oral hygiene and medical context (pathologies and associated drug therapies) of the patient. More than 1200 bacterial species have been identified, and among them, 400 are inhabitants of the sub-gingival biofilm. Among all these microorganismes, only 20 species participate to the etiopathogenesis of periodontal diseases.Some are recognised as major periodontopathogens other play unclear role in this pathology. They belong respectively to the red and orange complex of Socransky et al. (1998).

Other microorganismes such as virures, yeasts and protozoans could potentially impact the emergence and development of periodontal diseases. The presence of protozoans in periodontitis have been investigated in this study.

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

50

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients consulting in the periodontal department of CHU, Nancy.

Description

Inclusion Criteria:

  • Adults > 18 years-old
  • Consulting in periodontal department of CHU, Nancy
  • Patient with moderate to severe periodontitis
  • At least 2 periodontal sites with PPD≥ 4mm and One healthy site
  • No scaling root planning in the last 6 months
  • Patients insured under the French social security system

Exclusion Criteria:

  • Pregnant patients
  • Patients with antibiotic therapy, and/or all medecines which could modify the buccal microbiota in the last 6 months
  • Tooth with endodontic periapical lesion
  • Patients having a scaling root planning in the last 6 months
  • Patient with guardianship

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Presence of protozoans
Time Frame: baseline
baseline

Secondary Outcome Measures

Outcome Measure
Time Frame
Periodontal pocket depth (mm)
Time Frame: baseline
baseline
Clinical attachment loss (mm)
Time Frame: baseline
baseline
Plaque and gingival index
Time Frame: baseline
baseline
Mobility of the tooth (Yes/No)
Time Frame: baseline
baseline
Presence of bleeding on probing (Yes/No)
Time Frame: baseline
baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Catherine BISSON, PhD, CHRU Nancy / Université de Lorraine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 3, 2013

Primary Completion (Actual)

November 11, 2014

Study Completion (Actual)

November 11, 2014

Study Registration Dates

First Submitted

June 6, 2017

First Submitted That Met QC Criteria

June 6, 2017

First Posted (Actual)

June 7, 2017

Study Record Updates

Last Update Posted (Actual)

November 14, 2017

Last Update Submitted That Met QC Criteria

November 13, 2017

Last Verified

November 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • PSS2016/PARO-PROTO-BISSON/VS

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Commission Nationale de l'Informatique et des libertés

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Periodontitis, Adult

3
Subscribe